BioGaia And Two More Top Dividend Stocks On The Swedish Exchange
In This Article:
Amidst a backdrop of global economic uncertainties and shifting market dynamics, the Swedish stock market presents unique opportunities for investors looking to enhance their portfolios with dividend stocks. As investors globally navigate through the complexities of trade tensions and technological disruptions, dividend-paying stocks like BioGaia offer a semblance of stability and potential for steady income.
Top 10 Dividend Stocks In Sweden
| Name | Dividend Yield | Dividend Rating |
| Betsson (OM:BETS B) | 6.18% | ★★★★★☆ |
| Nordea Bank Abp (OM:NDA SE) | 8.68% | ★★★★★☆ |
| Zinzino (OM:ZZ B) | 3.87% | ★★★★★☆ |
| HEXPOL (OM:HPOL B) | 3.35% | ★★★★★☆ |
| Duni (OM:DUNI) | 4.96% | ★★★★★☆ |
| Axfood (OM:AXFO) | 3.25% | ★★★★★☆ |
| Skandinaviska Enskilda Banken (OM:SEB A) | 5.32% | ★★★★★☆ |
| Avanza Bank Holding (OM:AZA) | 4.88% | ★★★★★☆ |
| Loomis (OM:LOOMIS) | 3.91% | ★★★★☆☆ |
| Bahnhof (OM:BAHN B) | 3.85% | ★★★★☆☆ |
Click here to see the full list of 19 stocks from our Top Swedish Dividend Stocks screener.
Let's uncover some gems from our specialized screener.
BioGaia
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: BioGaia AB is a healthcare company specializing in probiotic products with a market capitalization of approximately SEK 12.92 billion.
Operations: BioGaia AB generates its revenue primarily through the sale of probiotic products across global markets.
Dividend Yield: 5.4%
BioGaia's recent earnings show a robust increase, with Q2 sales up to SEK 384.12 million and net income at SEK 111.01 million. Despite a healthy payout ratio of 47.8%, indicating earnings cover dividends well, its dividend sustainability is questionable due to a high cash payout ratio of 193.4%. The company’s strategic expansion into Australia and New Zealand could bolster future prospects, yet its dividends have shown volatility over the past decade, reflecting some risk for dividend-focused investors.
-
Click here to discover the nuances of BioGaia with our detailed analytical dividend report.
-
Upon reviewing our latest valuation report, BioGaia's share price might be too pessimistic.
HEXPOL
Simply Wall St Dividend Rating: ★★★★★☆
Overview: HEXPOL AB (publ) specializes in the development, manufacture, and sale of polymer compounds and engineered products across Sweden, Europe, the Americas, and Asia with a market capitalization of SEK 41.16 billion.
Operations: HEXPOL AB generates SEK 20.18 billion from its Compounding segment and SEK 1.61 billion from its Engineered Products division.
Dividend Yield: 3.3%
HEXPOL AB, despite a recent dip in sales and net income as reported on July 17, 2024, maintains a moderate dividend yield of 3.35%, underperforming against the top quartile of Swedish dividend stocks at 4.15%. The company's dividends are well-supported by earnings and cash flows with payout ratios of 55.4% and 57.8% respectively, indicating sustainability. Dividend reliability is underscored by a decade-long stability in payouts, further bolstered by an increase to SEK 6 per share announced on April 26, reflecting a positive outlook for continuity despite leadership changes with Klas Dahlberg stepping in as CEO.